
Voglisis 0.3 Tablet
Marketer
Tycoon Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglisis 0.3 Tablet
DiaBeta 0.3mg tablets are prescribed for managing type 2 diabetes. This medication helps regulate elevated postprandial blood glucose. It's indicated when dietary modifications and other comparable treatments prove insufficient to maintain healthy blood sugar levels. DiaBeta 0.3mg should be administered immediately before meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinue use only under medical supervision; abrupt cessation may elevate blood glucose, potentially causing serious complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Frequent side effects may include gas, abdominal discomfort, appetite reduction, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While DiaBeta 0.3mg itself doesn't induce hypoglycemia, concurrent use with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. Hypoglycemic episodes require treatment with pure glucose; ordinary table sugar is ineffective in this context. Inform your doctor of any liver or kidney conditions before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should consult their physician prior to use. Disclose all other medications to ensure safe usage. Limit alcohol consumption while on this medication, as it may heighten the risk of hypoglycemia.
Primary Ingredients of Voglisis 0.3 Tablet
No text provided to rephrase.
Uses of Voglisis 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Voglisis 0.3 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglisis 0.3mg tablets should be administered on an empty stomach.
Common Side effects of Voglisis 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglisis 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglisis 0.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Voglisis 0.3 Tablet works:
Glycemia Control 0.3mg tablets offer anti-diabetic action. By suppressing intestinal enzymes that digest complex carbohydrates into glucose, they moderate post-prandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglisis 0.3 Tablet and alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
The use of Voglisis 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the use of Voglisis 0.3 Tablet while breastfeeding appears to pose minimal risk to the infant. Studies in humans indicate negligible danger to the nursing child.
DrivingSAFE
Driving ability is typically unaffected by Voglisis 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglisis 0.3 Tablet, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglisis 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglisis 0.3 Tablet :
Omit any missed Voglisis 0.3 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Voglisis 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
